Beth Israel Deaconess Medical Center investigator Kun Ping Lu, M.D., Ph.D., named AAAS Fellow

Beth Israel Deaconess Medical Center (BIDMC) investigator Kun Ping Lu, MD, PhD, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as a AAAS Fellow is an honor bestowed upon AAAS members by their peers.

Lu is among 702 members to be recognized this year for distinguished efforts to advance science, and will be honored during the 2013 AAAS Annual Meeting in February.

A faculty member in BIDMC's Division of Hematology/Oncology and Cancer Center, Lu was recognized for distinguished contributions to signal transduction mechanisms through controlling prolyl isomerization of key molecules in cell cycle control, tumor formation, and onset of neurodegenerative diseases.

"Dr. Lu's key discoveries have led to significant research advances in the fields of both Alzheimer's disease and cancer," says Vikas Sukhatme, MD, PhD, BIDMC's Chief Academic Officer. "This novel work provides the foundation for the development of patient therapies for two of today's most pressing clinical problems."

Lu joins the following BIDMC faculty as a AAAS fellow: Seth Alper, MD, PhD, Division of Nephrology; Lewis Cantley, PhD, Division of Signal Transduction; Harold Dvorak, MD, Center for Vascular Biology Research; Barbara Furie, PhD, Division of Hemostasis & Thrombosis; Jerome Groopman, MD, Division of Experimental Medicine; Barbara Kahn, MD, Division of Endocrinology, Diabetes & Metabolism; Mitchell Rabkin, MD, Carl J. Shapiro Institute for Education and Research; Clifford Saper, MD, PhD, Department of Neurology; Cox Terhorst, PhD, Division of Immunology; George Tsokos, MD, Division of Rheumatology; and Peter Weller, MD, Divisions of Infectious Diseases, Allergy and Immunology.

Provided by Beth Israel Deaconess Medical Center